Prunella vulgaris attenuates prepulse inhibition deficit and attention disruption induced by MK-801 in mice

Phytotherapy Research

Volumn 27, Issue 12, 2013, Pages 1763-1769

  Park, Se Jin ^a   Jeon, Se Jin ^b   Dela Peña, Ike C ^c   Lee, Hyung Eun ^a   Kim, Dong Hyun ^a   Kim, Jong Min ^a   Lee, Young Woo ^a   Jung, Jun Man ^a   Shin, Bum Young ^a   Lee, Seungheon ^d   Cheong, Jae Hoon ^c   Shin, Chan Young ^b   Jang, Dae Sik ^a   Ryu, Jong Hoon ^a  

^a Kyung Hee University   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

^c Sahmyook University   (South Korea)

^d Jeju National University   (South Korea)

Author keywords

MK 801; prepulse inhibition; Prunella vulgaris var. lilacina; schizophrenia

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; PRUNELLA VULGARIS EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN CORTEX; BRAIN REGION; BRAIN TISSUE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; PREPULSE INHIBITION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SCHIZOPHRENIA; STARTLE REFLEX;

EUROPEAN ELK PAPILLOMAVIRUS; MUS; PRUNELLA VULGARIS;

MK-801; PREPULSE INHIBITION; PRUNELLA VULGARIS VAR. LILACINA; SCHIZOPHRENIA;

ANIMALS; ATTENTION; CEREBRAL CORTEX; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DIZOCILPINE MALEATE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLYCOGEN SYNTHASE KINASE 3; HIPPOCAMPUS; MALE; MICE; MICE, INBRED ICR; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PLANT EXTRACTS; PROTO-ONCOGENE PROTEINS C-AKT; PRUNELLA; SCHIZOPHRENIA; STARTLE REACTION;

EID: 84890566655     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4929     Document Type: Article

References (51)

1. Adell A, Jimenez-Sanchez L, Lopez-Gil X, Romon T,. 2012. Is the acute NMDA receptor hypofunction a valid model of schizophrenia? Schizophr Bull 38: 9-14.
2. Ahn YM, Seo MS, Kim SH, Kim Y, Juhnn YS, Kim YS,. 2006. The effects of MK-801 on the phosphorylation of Ser338-c-Raf-MEK-ERK pathway in the rat frontal cortex. Int J Neuropsychopharmacol 9: 451-456.
3. Ahn YM, Seo MS, Kim SH, et al,. 2005. Increased phosphorylation of Ser473-Akt, Ser9-GSK-3β and Ser133-CREB in the rat frontal cortex after MK-801 intraperitoneal injection. Int J Neuropsychopharmacol 8: 607-613.
4. Aleman A, Hijman R, de Haan EH, Kahn RS,. 1999. Memory impairment in schizophrenia: a meta-analysis. Am J Psychiatry 156: 1358-1366.
5. Ballmaier M, Bortolato M, Rizzetti C, et al,. 2007. Cannabinoid receptor antagonists counteract sensorimotor gating deficits in the phencyclidine model of psychosis. Neuropsychopharmacology 32: 2098-2107.
6. 2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle. Neuropsychopharmacology 30: 561-574.
7. Bortolato M, Frau R, Orru M, et al,. 2008. Antipsychotic-like properties of 5-α-reductase inhibitors. Neuropsychopharmacology 33: 3146-3156.
8. Braff DL, Geyer MA,. 1990. Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry 47: 181-188.
9. Braff DL, Geyer MA, Swerdlow NR,. 2001. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 156: 234-258.
10. Casey DE,. 1993. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia. Psychiatr Clin North Am 16: 589-610.
11. Chakos M, Lieberman J, Hoffman E, Bradford D, Sheitman B,. 2001. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am J Psychiatry 158: 518-526.
12. Duncan GE, Moy SS, Lieberman JA, Koller BH,. 2006a. Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function. Psychopharmacology (Berl) 184: 190-200.
13. Duncan GE, Moy SS, Lieberman JA, Koller BH,. 2006b. Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction. Pharmacol Biochem Behav 85: 481-491.
14. Field JR, Walker AG, Conn PJ,. 2011. Targeting glutamate synapses in schizophrenia. Trends Mol Med 17: 689-698.
15. Floresco SB, Geyer MA, Gold LH, Grace AA,. 2005. Developing predictive animal models and establishing a preclinical trials network for assessing treatment effects on cognition in schizophrenia. Schizophr Bull 31: 888-894.
16. Freyberg Z, Ferrando SJ, Javitch JA,. 2010. Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action. Am J Psychiatry 167: 388-396.
17. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR,. 2001. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 156: 117-154.
18. Geyer MA, Swerdlow NR,. 2001. Measurement of startle response, prepulse inhibition, and habituation. Curr Protoc Neurosci Chapter 8: Unit 8 7.
19. Hawk LW, Jr., Yartz AR, Pelham WE, Jr., Lock TM,. 2003. The effects of methylphenidate on prepulse inhibition during attended and ignored prestimuli among boys with attention-deficit hyperactivity disorder. Psychopharmacology (Berl) 165: 118-127.
20. Ishii D, Matsuzawa D, Kanahara N, et al,. 2010. Effects of aripiprazole on MK-801-induced prepulse inhibition deficits and mitogen-activated protein kinase signal transduction pathway. Neurosci Lett 471: 53-57.
21. Javitt DC, Zukin SR,. 1991. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148: 1301-1308.
22. Jentsch JD, Roth RH,. 1999. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20: 201-225.
23. Jentsch JD, Tran A, Taylor JR, Roth RH,. 1998. Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: behavioral and neurochemical evidence. Psychopharmacology (Berl) 138: 89-95.
24. Keith VA, Mansbach RS, Geyer MA,. 1991. Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle. Biol Psychiatry 30: 557-566.
25. Krystal JH, Karper LP, Seibyl JP, et al,. 1994. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51: 199-214.
26. Lamaison JL, Petitjean-Freytet C, Carnat A,. 1991. Medicinal Lamiaceae with antioxidant properties, a potential source of rosmarinic acid. Pharm Acta Helv 66: 185-188.
27. Levkovitz Y, Levi U, Braw Y, Cohen H,. 2007. Minocycline, a second-generation tetracycline, as a neuroprotective agent in an animal model of schizophrenia. Brain Res 1154: 154-162.
28. Lieberman JA, Stroup TS, McEvoy JP, et al,. 2005. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353: 1209-1223.
29. Lopez-Gil X, Babot Z, Amargos-Bosch M, Sunol C, Artigas F, Adell A,. 2007. Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat. Neuropsychopharmacology 32: 2087-2097.
30. Miyamoto S, Duncan GE, Marx CE, Lieberman JA,. 2005. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry 10: 79-104.
31. Molteni R, Calabrese F, Racagni G, Fumagalli F, Riva MA,. 2009. Antipsychotic drug actions on gene modulation and signaling mechanisms. Pharmacol Ther 124: 74-85.
32. 2A receptors. Behav Brain Res 218: 165-173.
33. 1 receptors. Neuropsychopharmacology 24: 451-460.
34. Park SJ, Kim DH, Kim JM, et al,. 2010a. Mismatch between changes in baicalein-induced memory-related biochemical parameters and behavioral consequences in mouse. Brain Res 1355: 141-150.
35. Park SJ, Kim DH, Lee IK, et al,. 2010b. The ameliorating effect of the extract of the flower of Prunella vulgaris var. lilacina on drug-induced memory impairments in mice. Food Chem Toxicol 48: 1671-1676.
36. Pereira A, Fink G, Sundram S,. 2009. Clozapine-induced ERK1 and ERK2 signaling in prefrontal cortex is mediated by the EGF receptor. J Mol Neurosci 39: 185-198.
37. Perry W, Minassian A, Feifel D, Braff DL,. 2001. Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania. Biol Psychiatry 50: 418-424.
38. Porsolt RD, Moser PC, Castagne V,. 2010. Behavioral indices in antipsychotic drug discovery. J Pharmacol Exp Ther 333 (3): 632-638.
39. Powell SB, Zhou X, Geyer MA,. 2009. Prepulse inhibition and genetic mouse models of schizophrenia. Behav Brain Res 204: 282-294.
40. Seo MS, Kim SH, Ahn YM, et al,. 2007. The effects of repeated administrations of MK-801 on ERK and GSK-3β signalling pathways in the rat frontal cortex. Int J Neuropsychopharmacol 10: 359-368.
41. Stefani MR, Moghaddam B,. 2005. Transient N-methyl- d -aspartate receptor blockade in early development causes lasting cognitive deficits relevant to schizophrenia. Biol Psychiatry 57: 433-436.
42. Swerdlow NR, Geyer MA,. 1998. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull 24: 285-301.
43. Thomas LE, Woods SW,. 2006. The schizophrenia prodrome: a developmentally informed review and update for psychopharmacologic treatment. Child Adolesc Psychiatr Clin N Am 15: 109-133.
44. Tuunainen A, Wahlbeck K, Gilbody S,. 2002. Newer atypical antipsychotic medication in comparison to clozapine: a systematic review of randomized trials. Schizophr Res 56: 1-10.
45. van Os J, Kapur S,. 2009. Schizophrenia. Lancet 374: 635-645.
46. Wiley JL, Kennedy KL,. 2002. Evaluation of the efficacy of antipsychotic attenuation of phencyclidine-disrupted prepulse inhibition in rats. J Neural Transm 109: 523-535.
47. Yang BH, Son H, Kim SH, Nam JH, Choi JH, Lee JS,. 2004. Phosphorylation of ERK and CREB in cultured hippocampal neurons after haloperidol and risperidone administration. Psychiatry Clin Neurosci 58: 262-267.
48. Yu J, Qi D, Xing M, et al,. 2011. MK-801 induces schizophrenic behaviors through downregulating Wnt signaling pathways in male mice. Brain Res 1385: 281-292.
49. Yuan P, Zhou R, Wang Y, et al,. 2010. Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia. J Affect Disord 124: 164-169.
50. Zhang L, Shirayama Y, Iyo M, Hashimoto K,. 2007. Minocycline attenuates hyperlocomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpine. Neuropsychopharmacology 32: 2004-2010.
51. Zhu YP,. 1998. Chinese Materia Medica: Chemistry, Pharmacology, and Applications. Harwood Academic: Amsterdam, The Netherlands.